doc. MUDr. Petr Kavan

131I-meta-iodobenzylguanidine in the treatment of the high risk neuroblastoma patients - Experiences from the Department of Pediatric Oncology in Faculty Hospital Motol in Prague

2001 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine

Publication